Schroder UK Public Private Tst plc Directorate Change (3990Q)
26 Febrero 2021 - 4:00AM
UK Regulatory
TIDMSUPP
RNS Number : 3990Q
Schroder UK Public Private Tst plc
26 February 2021
Schroder UK Public Private Trust plc
(the "Company")
Appointment of independent non-executive director
The Company is pleased to announce the appointment of Tim
Edwards as an independent non-executive director of the Company,
effective 26 February 2021. Mr Edwards will stand for election at
the Company's next Annual General Meeting ("AGM") and if elected,
will succeed Susan Searle as Chairman of the Company following her
retirement once the AGM has concluded. Mr Edwards has also been
appointed a member of the Audit, Risk and Valuation, Management
Engagement and Nomination Committees.
Tim is a qualified chartered accountant with a widespread
background in corporate finance and investment. He is currently the
chairman of Storm Therapeutics Ltd, Karus Therapeutics Ltd and
Modulus Oncology Ltd, a director of AstronauTx Ltd and an
independent non-executive director of Record plc. Previously, Tim
was a member of the governing board of InnovateUK, the UK's
innovation agency, a director of the UK Cell and Gene Therapy
Catapult and chairman of the UK BioIndustry Association.
At the date of this announcement , Mr Edwards holds no interests
in the shares of the Company. I t is confirmed that there are no
other details to be disclosed under FCA Listing Rule 9.6.13 R.
Susan Searle, on behalf of the Board, commented:
"The appointment of Tim is in line with the Board's agreed
succession plans, as outlined in the Annual Report for the year
ended 31 December 2019, and follows an extensive independent search
over the last twelve months to find a candidate with the
appropriate balance of skills and experience to complement those of
the current Directors. My colleagues and I are delighted to welcome
him to the Board and are very much looking forward to working with
him."
Enquiries:
Gareth Faith
Schroder Investment Management Limited
020 7658 5264
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAPPURAPUPGGCA
(END) Dow Jones Newswires
February 26, 2021 05:00 ET (10:00 GMT)
Woodford Patient Capital (LSE:WPCT)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Woodford Patient Capital (LSE:WPCT)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024